Immunome, Inc. US Stock
Open: $2.76 High: $3.5 Low: $2.42 Close: $3
Range: 2022-05-18 - 2022-05-19
Market: Extended-hours
Immunome, Inc. 665 STOCKTON DRIVE
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The company's primary focus areas are oncology and infectious disease, including COVID-19. It primarily operates in the U.S.
  • CEO:
  • Employees: 39
  • Sector:
  • Industry:
Latest Stocks Posts
Card image
Card image
Card image